cellular-agriculture
(9)
Calysta
Calysta is a San Mateo, California biotechnology company that uses a patented gas-fermentation platform to turn methane into FeedKind, a single-cell protein for aquaculture, livestock and pet feed - and increasingly human food. Its bacteria eat natural gas instead of arable land, plants or animals, producing protein with a low environmental footprint. Backed by Cargill, BP and Temasek and partnered with Adisseo through the Calysseo joint venture, Calysta opened the world's first industrial-scale single-cell protein plant in Chongqing, China in 2022.
Foray Bioscience
Foray Bioscience is a Cambridge, Massachusetts biotech company growing plants and plant products from single cells. Founded in 2022 by MIT PhD Ashley Beckwith, Foray pairs plant cell culture with AI to make lab-grown plant material predictable across species - unlocking harvest-free wood and materials, rapidly scalable seed supplies, faster crop improvement, and even conservation and de-extinction work. Its Pando software acts like a 'Google Maps for plant growth,' helping researchers navigate the dozens of variables that govern how a plant cell grows.
Fengru Lin
Fengru Lin is the co-founder and CEO of TurtleTree, a biotech company making dairy proteins without cows. A former Google account manager who took up cheesemaking as a hobby, she went hunting across Asia for clean raw milk, was horrified by what she found on the farms, and started a company to make milk in a lab instead. TurtleTree pivoted from full cell-cultured milk to precision fermentation, and now produces lactoferrin, a high-value milk protein once called 'pink gold,' using microbes instead of herds. She has raised roughly $44 million and made EDGE's 35 Under 35 and Her World's Young Woman Achiever lists.
Ashley Beckwith
Ashley Beckwith is the founder and CEO of Foray Bioscience, a Cambridge, Massachusetts biotech growing wood, plant materials, molecules, and seeds from single plant cells - no forests required. Out of her PhD in mechanical engineering at MIT, where she grew wood-like tissue in the lab from a zinnia leaf, she built a company that pairs in-vitro plant cell culture with an AI platform called Pando, billed as an operating system for plant science. The goal: shorten plant development from decades to months and bring biomanufacturing's precision to forestry and conservation.
TurtleTree
TurtleTree is a biotech and food-tech company that makes lactoferrin - one of the rarest and most valuable proteins in cow's milk - without the cow. Using precision fermentation, its flagship ingredient LF+ recreates the bioactive milk protein at scale for use in immunity, gut health, sports nutrition and infant nutrition products. In 2025 TurtleTree became the first company in the world to win an FDA 'No Questions' GRAS letter for precision-fermented lactoferrin, clearing it to commercialize in the U.S.
Fork & Good, Inc.
Fork & Good is a Jersey City-based cellular agriculture company growing real meat from animal cells instead of whole animals. Founded by urban-farming entrepreneur Niya Gupta and cultivated-meat pioneer Gabor Forgacs, the company built a pilot factory that produces cultivated pork using a patented bioprocess centered on muscle cells and high-density bioreactors. Its goal is to reach price parity with commodity meat - targeting roughly $2 per pound - while using a fraction of the land and water of conventional farming. In 2025 it acquired California's Orbillion Bio to combine cultivated pork and beef under one global platform spanning North America, Europe, Asia and the Middle East.
Niyati Gupta
Niyati Gupta is the co-founder and CEO of Fork & Good, a Jersey City cultivated-meat startup betting against the rest of its industry. While competitors chase ever-bigger bioreactors, Gupta builds small ones, arguing that the way to make cell-grown pork as cheap as the real thing is to copy the efficiency of a pig, not the scale of a brewery. A Yale economist and Harvard MBA who advised Nigeria's agriculture ministry and ran a rooftop farm in Singapore before being 'bullied' into starting Fork & Good, she has raised roughly $30M, earned the industry's first cultivated red-meat revenue via a deal with an $8B food manufacturer, and held a public tasting at Davos where half the tasters could not tell her blend from conventional pork.
Justin Kolbeck
Justin Kolbeck is Co-Founder and CEO of Wildtype, the San Francisco-based cultivated seafood company that became the first to receive FDA regulatory clearance for cell-grown salmon in the United States. A former U.S. Foreign Service Officer who served in Pakistan and Afghanistan, Kolbeck channeled his firsthand experience with global food insecurity into co-founding Wildtype in 2016 alongside cardiologist and microbiologist Aryé Elfenbein. The company has raised over $123 million in funding - including a record $100 million Series B backed by Leonardo DiCaprio, Jeff Bezos, and Robert Downey Jr. - and launched its sushi-grade coho salmon at award-winning restaurants in 2025. Wildtype's salmon, grown in stainless steel bioreactors in a converted San Francisco brewery, was named one of TIME's Best Inventions of 2025.
Wildtype
Wildtype is a San Francisco-based cultivated seafood company that grows real salmon from fish cells in stainless steel bioreactors - no fishing, no farming, no ocean required. Founded in 2016 by a cardiologist-turned-food-scientist and a former U.S. Foreign Service officer, the company received FDA clearance in May 2025, making it the first cultivated seafood product approved for sale in the United States. With $123.5M raised and backing from Jeff Bezos, Leonardo DiCaprio, and Cargill, Wildtype is betting that the future of seafood is grown, not caught.